Sigma Planning Corp
- SEC CIK
- 0001449126
- Latest filing
- Aug 7, 2026
INTS holding history
Intensity Therapeutics, Inc. in every 13F filed by Sigma Planning Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INTS overviewAll 13F holders of INTSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −56,432−100.0% | Sold out | Holders |
| Q4 2025 | 56,432 | $23.1K | <0.1% | −12,735−18.4% | Reduced | Holders |
| Q3 2025 | 69,167 | $16.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 69,167 | $21.2K | <0.1% | +14,330+26.1% | Added | Holders |
| Q1 2025 | 54,837 | $108.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 54,837 | $96.5K | <0.1% | +7,093+14.9% | Added | Holders |
| Q3 2024 | 47,744 | $182.4K | <0.1% | −125−0.3% | Reduced | Holders |
| Q2 2024 | 47,869 | $234.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 47,869 | $248.9K | <0.1% | +13,426+39.0% | Added | Holders |
| Q4 2023 | 34,443 | $295.2K | <0.1% | −13,701−28.5% | Reduced | Holders |
| Q3 2023 | 48,144 | $191.1K | <0.1% | +48,144 | New | Holders |